Mehmet Fatih ERBAY, Mehmet TAN, Tuba BAYINDIR, Mehmet Turan ÇİÇEK, Ebru ÖZER

Is diffusion-weighted magnetic resonance imaging (DW-MRI) a requirement for suspected cholesteatoma in patients to undergo primary surgery?

Aim: In this study, the aim was to investigate the correlation of preoperative diffusion-weighted magnetic resonance imaging (DWMRI) with postoperative pathology findings in patients undergoing tympanomastoidectomy with suspicion of primary cholesteatoma.Materials and Methods: The study consisted of the retrospective evaluation of preoperative MRIs, surgical findings and pathologyresults of patients who underwent tympanomastoidectomy and had preoperative DW-MRI at the Department of Otorhinolaryngologybetween the years 2017 and 2019.Results: The study was conducted with 199 patients who underwent tympanomastoidectomy surgery. A retrospective examinationof patient files revealed that 80 (40.2%) of the patients underwent echoplanar diffusion-weighted magnetic resonance imaging(DW-MRI) because of suspected cholesteatoma in the preoperative period. Of these 80 patients, cholesteatoma was detected in 22(27.5%) as a result of pathological analysis and/or surgery, but no diffusion restriction was found in MRI interpretation; in 44 (55%)of them, both cholesteatoma in pathological analysis and/or surgery and diffusion restriction in MRI interpretation were detected.In 10 (12.5%) of these 80 patients, cholesteatoma was not detected either in the MRI interpretation or in the pathological analysisand/or surgery. In the remaining 4 (5%) patients, there was a cholesteatoma suspicion in MRI, but it was not detected as a result ofpathological analysis or surgery. In this study, the sensitivity of MRI for the diagnosis of cholesteatoma was 66.6%, and its specificitywas 71.4%.Conclusion: MRI provides moderately (66.6%) reliable information in the diagnosis of cholesteatoma patients. However, it is morereliable (71.4%) when it comes to exclusion of the disease. Therefore, it should not be used as the sole determining factor in patientswho will undergo primary surgery with suspected cholesteatoma. As much as our study results provide guidance for a more accurateuse of imaging methods, series with higher numbers of patients are needed.

PDF

___

1. Aikele P, Kittner T, Offergeld C, et al. Diffusion-weighted MR imaging of cholesteatoma in pediatric and adult patients who have undergone middle ear surgery. AJR Am J Roentgenol 2003;181:261-5.
2. Mateos-Fernandez M, Mas-Estelles F, de PaulaVernetta C, et al . The role of diffusion-weighted magnetic resonance imaging in cholesteatoma diagnosis and follow-up. Study with the diffusion propeller technique. Acta Otorrinolaringol Esp 2012;63:436-42.
3. Tierney PA, Pracy P, Blaney SP, et al. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery. Clin Otolaryngol Allied Sci 1999;24:274-6.
4. Blaney SP, Tierney P, Oyarazabal M, et al. CT scanning in "second look" combined approach tympanoplasty. Rev Laryngol Otol Rhinol (Bord) 2000;121:79-81.
5. Plouin-Gaudon I, Bossard D, Fuchsmann C, et al. Diffusion-weighted MR imaging for evaluation of pediatric recurrent cholesteatomas. Int J Pediatr Otorhinolaryngol 2010;74:22-6.
6. Williams MT, Ayache D. Imaging of the postoperative middle ear. Eur Radiol 2004;14:482-95.
7. Kimitsuki T, Suda Y, Kawano H, et al. Correlation between MRI findings and second-Look operation in cholesteatoma surgery. ORL J Otorhinolaryngol Relat Spec 2001;63:291-3.
8. Yigiter AC, Pinar E, Imre A, et al. Value of Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging for Detecting Tympanomastoid Cholesteatoma. J Int Adv Otol 2015;11:53-7.
9. Vercruysse JP, De Foer B, Pouillon M, et al. The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients. Eur Radiol. 2006;16:1461-7.
10. Dubrulle F, Souillard R, Chechin D, et al. Diffusionweighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology 2006;238:604-10.
11. Khemani S, Lingam RK, Kalan A, et al. The value of nonecho planar HASTE diffusion-weighted MR imaging in the detection, localisation and prediction of extent of postoperative cholesteatoma. Clin Otolaryngol 2011;36:306-12.
12. Ilica AT, Hidir Y, Bulakbasi N, Satar B, et al. HASTE diffusion-weighted MRI for the reliable detection of cholesteatoma. Diagn Interv Radiol 2012;18:153-8.
13. Cimsit NC, Cimsit C, Baysal B, et al. Diffusion-weighted MR imaging in postoperative follow-up: reliability for detection of recurrent cholesteatoma. Eur J Radiol 2010;74:121-3.
14. De Foer B, Vercruysse JP, Pilet B, et al. Single-shot, turbo spin-echo, diffusion-weighted imaging versus spin-echo-planar, diffusion-weighted imaging in the detection of acquired middle ear cholesteatoma. AJNR Am J Neuroradiol 2006;27:1480-2.
15. Profant M, Slavikova K, Kabatova Z, et al. Predictive validity of MRI in detecting and following cholesteatoma. Eur Arch Otorhinolaryngol 2012;269:757-65.
16. Li PM, Linos E, Gurgel RK, Fischbein NJ, et al. Evaluating the utility of non-echo-planar diffusionweighted imaging in the preoperative evaluation of cholesteatoma: a meta-analysis. Laryngoscope 2013;123:1247-50.
17. Garcia-Iza L, Guisasola A, Ugarte A, et al. Utility of diffusion-weighted magnetic resonance imaging in the diagnosis of cholesteatoma and the influence of the learning curve. Eur Arch Otorhinolaryngol 2018;275:2227-35.
18. Akkari M, Gabrillargues J, Saroul N, et al. Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:153-8.
19. Muzaffar J, Metcalfe C, Colley S, et al. Diffusionweighted magnetic resonance imaging for residual and recurrent cholesteatoma: a systematic review and meta-analysis. Clin Otolaryngol 2017;42:536-43.
20. Garrido L, Cenjor C, Montoya J, Alonso A, et al. Diagnostic capacity of non-echo planar diffusionweighted MRI in the detection of primary and recurrent cholesteatoma. Acta Otorrinolaringol Esp 2015;66:199-204.
21. De Foer B, Vercruysse JP, Bernaerts A, et al. Detection of postoperative residual cholesteatoma with nonecho-planar diffusion-weighted magnetic resonance imaging. Otol Neurotol 2008;29:513-7.
22. Vercruysse JP, De Foer B, Pouillon M, et al. The Value of Diffusion-Weighted MR Imaging in the Diagnosis of Primary Acquired and Residual Cholesteatoma: A Surgical Verified Study of 100 Patients Eur Radiol 2006;16:1461-7.
23. Horn RJ, Gratama JWC, van der Zaag-Loonen HJ, et al. Negative Predictive Value of Non-Echo-Planar Diffusion Weighted MR Imaging for the Detection of Residual Cholesteatoma Done at 9 Months After Primary Surgery Is not High Enough to Omit Second Look Surgery. Otol Neurotol 2019;40:911-9.
24. Ide S, Ganaha A, Tono T, Goto T,et al. Value of DWMRI in the preoperative evaluation of congenital cholesteatoma. Int J Pediatr Otorhinolaryngol 2019;124:34-8.
25. Mas-Estelles F, Mateos-Fernandez M, CarrascosaBisquert B, et al. Contemporary non-echoplanar diffusion-weighted imaging of middle ear cholesteatomas. Radiographics 2012;32:1197-213.
26. Fitzek C, Mewes T, Fitzek S, Mentzel HJ, et al. Diffusionweighted MRI of cholesteatomasof the petrous bone. J Magn Reson Imaging 2002;15:636-41.